Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: [68Ga]GA-NeoB
Sponsor: St Vincent's Hospital, Sydney
Collaborators: Novartis